Share
Recent studies have shown how stem cell-derived therapies have the potential as a renewable source of insulin-producing pancreatic islet cells. Promising as these results are, could stem cell technology eventually lead to a cure for diabetes as well as impacts well beyond endocrinology? Last December, two papers appeared in Cell Stem Cell and Cell Reports...
Share
People with type 2 diabetes who have cognitive impairment could be at greater risk for stroke, heart attack, or death than other individuals with diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. Cognitive impairment is when a person has trouble remembering, learning new things, concentrating, or making...
Share
Use of the drug verapamil to treat type 1 diabetes continues to show benefits lasting at least two years, according to a recent report in Nature Communications. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits....
Share
A review recently published in Endocrinology offers some new insights on how maternal obesity-associated gestational diabetes (GDM) affects the reproductive health of offspring, discussing possible mechanisms, the latest perceptions, and highlighting areas that need further investigation. The review, by Niharika Sinha, PhD; Gretchen Lydia Walker; and Aritro Sen, PhD, all of Michigan State University in...
Share
A newly discovered hormone named fabkin helps regulate metabolism and may play an important role in the development of both type 1 and type 2 diabetes, according to research led by the Sabri Ülker Center for Metabolic Research at Harvard T.H. Chan School of Public Health. The findings were published in Nature. The study showed blood...
Share
In October, DreaMed Diabetes AI LTD. announced that it received its fourth U.S. Food and Drug Administration (FDA) clearance for its Advisor Pro AI Clinical Decision Support System, which expands the platform’s target population to patients with both type 1 and type 2 diabetes. Advisor Pro is a decision support system cleared to assist healthcare providers...
Share
The gap in the use of insulin pumps and continuous glucose monitors (CGMs) among Black and white Medicare beneficiaries widened from 2017 to 2019, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Reducing health disparities is a major public health goal in the U.S., and these disparities include the use of diabetes technology. All Medicare beneficiaries with type 1 diabetes...
Share
In patients who have diabetes and end-stage kidney disease (ESKD), the rates of severe hypoglycemia crises requiring emergency department visits or hospitalizations are the highest so far reported, according to a nationwide study recently published in Diabetes Care. Researchers led by Rodolfo J. Galindo, MD, FACE, associate professor of medicine at Emory University School of...
